Fig. 3.
Fig. 3. Overall survival and CR duration for eligible and evaluable patients on CALGB 9022. The median survival time is 1.8 years and the median length of remission is 1 year.

Overall survival and CR duration for eligible and evaluable patients on CALGB 9022. The median survival time is 1.8 years and the median length of remission is 1 year.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal